Jane Street Group, LLC Galectin Therapeutics Inc Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$1.61 - $2.31 $67,781 - $97,251	-42,100 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$2.07 - $3.8 $10,350 - $19,000	-5,000 Reduced 10.62%	42,100 $87,000
Q3 2021 Nov 16, 2021	BUY	$2.59 - $4.15 $89,355 - $143,175	34,500 Added 273.81%	47,100 $183,000
Q2 2021 Aug 16, 2021	BUY	$2.07 - $5.1 $26,081 - $64,259	12,600 New	12,600 $40,000

10M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.1M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.